Beat Müllhaupt
Beat Müllhaupt is an expert in Hepatology at University Hospital of Zurich (Switzerland). As of October 2026, ScienceLeadR ranks Beat Müllhaupt in the top 1% of experts worldwide for Hepatitis. Beat Müllhaupt has authored 507 publications, the most recent in 2026, and is an investigator in 17 clinical trials, 1 of them ongoing. SLR score: 1,284 (community average: 125). How the SLR is computed.
LeadR Profile
Hepatology
Subspecialties: Infectiology - Gastroenterology - Transplantation
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1990 - 2026
Number : 507
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Clinical course, prognostic markers, and transplant implications in COVID-19-associated secondary sclerosing cholangitis. PMID 42616061 — cholangitis, transaminases, liver, covid-19, cholangitis, sclerosing, critical illness, transplants, gastrointestinal diseases | J Gastroenterol | 2026 | 0 |
| Hepatitis E Virus Infection in Swiss Transplant Recipients: Seroprevalence, Incidence, and the Role of Transfused Blood Products. PMID 42578274 — hepatitis e virus, blood, incidence, viruses, blood donors, hepatitis e, transplants, transplantation, infections, hepatitis, virus diseases | Transpl Infect Dis | 2026 | 0 |
| Peribiliary cysts on MRI: review of imaging features and associated clinical features. PMID 42406038 — liver diseases, bile, bile ducts, cysts, liver | Abdom Radiol (NY) | 2026 | 0 |
| Surgical management of cystic echinococcosis-A 20-year case series and outcome analysis. PMID 42030278 — mortality, echinococcosis, cysts, therapeutics | PLoS Negl Trop Dis | 2026 | 0 |
| Efficacy and safety of bulevirtide in patients with chronic hepatitis D treated under early access in Switzerland: a retrospective analysis. PMID 41962069 — hepatitis d, safety, hepatitis d, chronic, hepatitis, chronic, liver, drug-related side effects and adverse reactions, clinical medicine, therapeutics, hepatitis | Swiss Med Wkly | 2026 | 0 |
Clinical Studies 17
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 71
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Research Study on Whether Semaglutide Works in People With Non alcoholic Steatohepatitis (NASH) NCT04822181 — liver diseases, skin, non-alcoholic fatty liver disease, liver, alcoholics, research, fatty liver, fatty liver, alcoholic, semaglutide | Phase 3 | Active not recruiting | 2021 |
LeadR Networks
Main global connection map